China Metastatic Liver Cancer Clinical Registry Cohort Database

Recruiting now

Conditions studied: Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms, Liver Diseases, Colorectal Cancer Metastatic

In brief

This study is led by the Department of Hepatobiliary Surgery of the First Affiliated Hospital of the University of Science and Technology of China (USTC), in close collaboration with multiple participating centers nationwide. The primary objective is to establish a standardized, large-scale clinical cohort database specifically for metastatic liver cancer. By collecting comprehensive data on patient demographics, primary tumor characteristics, systemic therapies, and local interventions, this registry aims to elucidate the clinical patterns and prognostic factors of secondary liver malignancies. This database will serve as a robust platform for conducting high-quality real-world studies and advancing evidence-based clinical research in the management of metastatic liver cancer.

Key facts

Study ID
NCT07602504
Run by
Anhui Provincial Hospital
People needed
2000
Starts
2026-06-01
Expected to finish
2036-05-31
Last updated by the study team
2026-05-22

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.